Luxin Venture Capital
Funding rounds backed by Luxin Venture Capital.
- Funding disclosed in full
- $110M
- Median round
- $110M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Oricell Therapeutics Develops next-generation cell therapies for oncology and immunology | $110MPre-IPO | BiotechChina |